ATI LPN
Wong's Essentials of Pediatric Nursing 11th Edition Test Bank
Chapter 25 : The Child with Cancer Questions
Question 1 of 5
The parents of a child with cancer tell the nurse that a bone marrow transplant (BMT) may be necessary. What information should the nurse recognize as important when discussing this with the family?
Correct Answer: D
Rationale: HLA matching is critical for successful BMT, ensuring donor compatibility. BMT timing varies by disease, parents share only about 50% genetic material, and discussing post-failure treatments is premature during initial planning.
Question 2 of 5
An adolescent will receive a bone marrow transplant (BMT). The nurse should explain that the bone marrow will be administered by which method?
Correct Answer: B
Rationale: Bone marrow is administered via intravenous infusion, allowing stem cells to migrate to the recipient?s marrow for repopulation. Bone grafting, injection, or intraabdominal infusion are not used for BMT.
Question 3 of 5
After chemotherapy is begun for a child with acute leukemia, prophylaxis to prevent acute tumor lysis syndrome includes which therapeutic intervention?
Correct Answer: A
Rationale: Hydration prevents acute tumor lysis syndrome by reducing metabolic complications (e.g., hyperuricemia, hyperkalemia) from cell breakdown during leukemia treatment. Oxygenation, corticosteroids, and pain management don?t address this syndrome directly.
Question 4 of 5
Nursing care of the child with myelosuppression from leukemia or chemotherapeutic agents should include which therapeutic intervention?
Correct Answer: C
Rationale: Good hand-washing reduces infection risk in myelosuppressed children by minimizing exposure to pathogens. Oral fluids are encouraged, strict isolation isn?t needed, and immunizations are ineffective or risky during immunosuppression.
Question 5 of 5
In teaching parents how to minimize or prevent bleeding episodes when the child is myelosuppressed, the nurse includes what information?
Correct Answer: A
Rationale: Meticulous mouth care prevents gingival bleeding and mucositis in myelosuppressed children with low platelets. Rectal temperatures and intramuscular injections risk bleeding and infection, and platelet transfusions are typically given below 10,000/mm3 or with active bleeding.